VPAG payment rate for newer medicines will be 14.5% in 2026
The government has announced that the 2026 payment rate for newer medicines under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) will be 14.5 per cent, down from a record 22.5…
Read the full articleYou might also wanna read
Drugmakers Plan Price Increases on 350+ Medications Despite Government Pressure
Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster
reuters.com·6mo agoAbbVie, Trump Reach Drug Pricing Deal That Could Cut Costs for Older Americans
Breaking news: New deal between AbbVie and the Trump administration could reshape drug costs, tariffs, and how seniors buy medications in 20
€1 in, €5.67 out: How spending on medicines pays back in Europe’s health and economic future
Europe’s spending on innovative medicines buys more than health. A new report shows that every euro returns more than five times in economic
Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
Samuel Cross, Karl Claxton, and Andrew Hill argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade
bmj.com·8d agoAnalysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
Samuel Cross, Karl Claxton, and Andrew Hill argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade
bmj.com·8d ago
NHS trusts fail to account for over £400m in medical student training funds, BMJ investigation finds
Lack of transparency in how funding from NHS England for undergraduate medical training is spent suggests trusts are treating universities l
bmj.com·17d ago
Indian Man's Viral US Medical Bill Sparks Debate After ₹2,500 Medicines in India Cost ₹42,000 in the US
An Indian man's viral US medical bill comparing ₹2,500 medicines in India with ₹42,000 costs in the US reignites healthcare affordability de
Comments
Sign in to join the conversation.
No comments yet. Be the first.